Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4524410 | 5697493 | I | 4524410-7 | 20040713 | 20040501 | 20041117 | PER | 2004S1003110 | MYLAN PHARMACEUTICALS INC. | 67 | YR | M | N | 20041018 |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4524410 | 1005480448 | PS | APO-GO(APOMORPHINE HCL)10 MG/ML BRITANNIA | 2 | SUBCUTANEOUS | 60MG OVER 12 HOURS, SUBCUTANEOUS | D | D | 21264 | ||
| 4524410 | 1005501952 | C | SELEGELINE (1.25MG/DAY) | 2 | |||||||
| 4524410 | 1005501954 | C | NIFEDINE (20MG/DAY) | 2 | |||||||
| 4524410 | 1005501958 | C | NITROGLYCERIN SPARY | 2 | |||||||
| 4524410 | 1005501961 | C | CARBIDOPA/LEVODOPA(62.5MG/DAY) | 2 | |||||||
| 4524410 | 1005501963 | C | CARBEGOLINE (3MG/DAY) | 2 | |||||||
| 4524410 | 1005501965 | C | CARBIDOPA/LEVODOPA CR | 2 | |||||||
| 4524410 | 1005501970 | C | ATENOLOL | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4524410 | 1005480448 | PARKINSON'S DISEASE |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4524410 | HO |
| 4524410 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 4524410 | LEFT VENTRICULAR FAILURE |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4524410 | FGN |
| 4524410 | HP |
| 4524410 | OTH |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4524410 | 1005480448 | 20040225 |